What is Universal Sequencing Technology?
Universal Sequencing Technology is a key player in the advanced DNA sequencing solutions sector. The company develops and offers innovative products, including TELL-Seq Library Prep Kits and AmpliDrop Single Cell Kits, designed to enhance genomic research capabilities. Their specialized services encompass single cell sequencing and metagenomics applications, serving a critical role for researchers focused on microbial analysis and genome sequencing. By enabling short-read sequencing platforms to achieve long-read results, Universal Sequencing Technology is at the forefront of supporting scientific discovery and innovation.
How much funding has Universal Sequencing Technology raised?
Universal Sequencing Technology has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Universal Sequencing Technology
PPP
Public-Private Partnership
What's next for Universal Sequencing Technology?
With its substantial late-stage funding, Universal Sequencing Technology is poised for accelerated growth and market expansion. The recent strategic investment signals strong confidence from backers in the company's technology and its potential to revolutionize genomic research. This capital will likely be directed towards scaling operations, further research and development of their proprietary sequencing technologies, and broadening their market reach. The company's focus on enabling long-read sequencing capabilities on short-read platforms positions it to capture significant market share and drive further advancements in fields ranging from clinical diagnostics to fundamental biological research.
See full Universal Sequencing Technology company page
